Cell Biology

Lipid Droplets

The cell's fat-storage organelle — monolayer-bound, perilipin-coated, ER-born

Lipid droplets are the cell's dedicated fat-storage organelles — a neutral-lipid core of triacylglycerol and sterol esters wrapped in a single phospholipid monolayer studded with perilipin coat proteins. Uniquely among organelles, they are bounded by a monolayer rather than a bilayer, because they bud from the endoplasmic reticulum where enzymes such as DGAT1/2 esterify fatty acids into an oily lens between the two ER leaflets. Cells release the stored energy by lipolysis — ATGL, hormone-sensitive lipase, and monoacylglycerol lipase stripping fatty acids one by one — and by lipophagy, an autophagic route to the lysosome. Fat burns at roughly nine kilocalories per gram, more than double carbohydrate, which is why droplets are the body's densest fuel depot. Their overload underlies obesity and non-alcoholic fatty liver disease, the most common chronic liver disorder on Earth.

  • BoundarySingle phospholipid monolayer
  • CoreTriacylglycerol + sterol esters
  • Coat proteinsPerilipins PLIN1–5
  • Born fromEndoplasmic reticulum (seipin)
  • Energy density~9 kcal/g fat
  • Overload diseaseObesity, MASLD (fatty liver)

Interactive visualization

Press play, or step through manually. The visualization is yours to drive — try it before reading on.

Open visualization fullscreen ↗

Watch the 60-second explainer

A condensed visual walkthrough — narrated, captioned, under a minute.

Why lipid droplets matter

  • The body's densest fuel reserve. Fat stores about nine kilocalories per gram versus roughly four for carbohydrate or protein, and it stores dry — glycogen drags along three to four grams of water per gram of sugar, while triacylglycerol in a droplet is anhydrous. A lean 70-kg adult carries only about 2,000 kcal as glycogen but tens of thousands of kilocalories as droplet fat, enough to survive weeks of starvation.
  • A lipotoxicity buffer. Free fatty acids and free cholesterol are chemically reactive and damage membranes, mitochondria, and insulin signaling. By esterifying them into inert triacylglycerol and sterol esters and sealing them in a droplet, the cell neutralizes the threat. Blocking droplet formation (for example, inhibiting DGAT) can paradoxically worsen lipotoxicity by leaving fatty acids unbuffered.
  • A membrane and signaling reservoir. Droplet lipids are hydrolyzed not only for fuel but to supply phospholipid precursors for membrane growth during proliferation, and to release arachidonic acid and other precursors of eicosanoid signaling lipids.
  • The cell type that is almost all droplet. A mature white adipocyte is dominated by a single unilocular lipid droplet that can occupy 90 percent of the cell volume, squashing the nucleus and cytoplasm into a thin rim. Brown and beige adipocytes instead hold many small multilocular droplets feeding densely packed mitochondria for heat production.
  • Obesity is droplet biology. Weight gain is, at the cellular level, the enlargement of adipocyte droplets (hypertrophy) plus the recruitment of new fat cells (hyperplasia). Understanding droplet dynamics is understanding the central lesion of the obesity epidemic.
  • Fatty liver, the world's commonest liver disease. Ectopic droplet accumulation in hepatocytes defines MASLD, present in roughly a quarter to a third of adults globally and rising with obesity and type 2 diabetes.
  • A pathogen's target. Hepatitis C virus assembles its particles on the lipid-droplet surface, and Mycobacterium tuberculosis feeds on host droplets inside macrophages. Droplets are also a first-line innate-immune platform, concentrating antimicrobial proteins.

Common misconceptions

  • Lipid droplets are inert fat blobs. They are dynamic organelles with a regulated proteome of hundreds of proteins, dedicated biogenesis machinery (seipin, DGAT, FIT2), specific turnover pathways, and membrane contact sites with the ER, mitochondria, and peroxisomes. The "inert inclusion" view was overturned in the 1990s–2000s.
  • They are surrounded by a membrane like other organelles. They are wrapped in a single phospholipid monolayer, not a bilayer. This is a topological consequence of storing an oil that excludes water, and it dictates a unique proteome anchored by amphipathic helices and hairpin domains rather than transmembrane segments.
  • Only fat cells have them. Nearly every eukaryotic cell — and many bacteria and archaea — makes lipid droplets, from yeast to plant seeds (where they are called oil bodies or oleosomes) to hepatocytes, muscle, and immune cells. Adipocytes simply specialize in one enormous droplet.
  • Lipolysis is the only way out. Lipophagy — autophagic delivery of droplets to the lysosome for hydrolysis by lysosomal acid lipase — is a major, distinct route, dominant in the fasting liver. Cells run both classical cytosolic lipolysis and lysosomal lipophagy in parallel.
  • Bigger droplets are always better storage. Beyond a point, droplet enlargement outstrips the cell's ability to buffer the lipid flux; overflow into diacylglycerol and ceramide drives insulin resistance and inflammation. In fatty liver, the problem is not that fat is stored but that storage capacity is overwhelmed.
  • Droplets and mitochondria are separate systems. In oxidative tissues, PLIN5 physically tethers droplets to mitochondria, and peridroplet mitochondria form a functionally distinct subpopulation that channels liberated fatty acids straight into beta-oxidation. Storage and combustion are physically coupled.

How lipid droplets work

Biogenesis in the ER. A lipid droplet is born in the endoplasmic reticulum. Membrane-embedded acyltransferases esterify fatty acids into triacylglycerol — DGAT1 and DGAT2 catalyze the final step — while ACAT1/2 (SOAT1/2) esterify cholesterol into sterol esters. These neutral lipids are insoluble in the phospholipid bilayer, so once their local concentration exceeds roughly 5 to 10 mole percent they demix and coalesce into an oily lens between the two leaflets of the ER membrane. The protein seipin, encoded by BSCL2, assembles into a cage-like undecameric ring that surrounds and stabilizes the nascent droplet, controls its diameter, and concentrates the lipid-synthesis machinery at the budding site. Asymmetry in phospholipid content and surface tension biases the lens to bulge toward the cytosol and pinch off, carrying only the cytosolic leaflet — hence the mature droplet's defining single monolayer.

The monolayer and its proteome. The surface is a phospholipid monolayer, roughly 2 to 3 nm thick, enriched in phosphatidylcholine and depleted of phosphatidylethanolamine, a composition that keeps droplets from fusing. Because there is no inner water-facing leaflet, droplet proteins cannot use transmembrane domains; instead they embed by amphipathic helices (class II proteins such as the perilipins, which target from the cytosol) or by hydrophobic hairpins that partition from the ER (class I proteins such as DGAT2 and GPAT4). Perilipins PLIN1–5 are the signature coat: in the fed state PLIN1 shields the droplet from lipases; on hormonal demand, protein kinase A phosphorylates PLIN1, releasing its bound co-activator CGI-58 (ABHD5) to switch on lipolysis.

Mobilization: lipolysis and lipophagy. Classical lipolysis is a three-enzyme relay on the droplet surface. Adipose triglyceride lipase (ATGL/PNPLA2), activated by CGI-58, removes the first fatty acid to yield diacylglycerol; hormone-sensitive lipase (HSL/LIPE) removes the second to yield monoacylglycerol; monoacylglycerol lipase (MGL) removes the third, freeing glycerol. The three liberated fatty acids are exported or handed directly to mitochondria and oxidized by beta-oxidation for ATP. In parallel, lipophagy engulfs droplet fragments or whole small droplets in autophagosomes and delivers them to the lysosome, where lysosomal acid lipase (LIPA) hydrolyzes the triacylglycerol; this route dominates in the fasting liver and clears damaged lipids. Storage and release are tuned continuously so the cell always has a fatty-acid supply matched to demand.

Lipid droplet vs other organelles

FeatureLipid dropletMitochondrionLysosomePeroxisome
BoundarySingle phospholipid monolayerDouble membrane (bilayers)Single bilayerSingle bilayer
InteriorAnhydrous neutral-lipid oilAqueous matrixAcidic aqueous lumenAqueous matrix
OriginBuds from ER (seipin)Division of existing mitochondriaER–Golgi / endosomal maturationER + division
Protein targetingAmphipathic helices, hairpinsTOM/TIM import; own DNAMannose-6-phosphate tagsPTS1/PTS2 + Pex machinery
Core functionStore & release neutral lipidATP synthesis, fatty-acid oxidationHydrolytic degradationVery-long-chain FA oxidation, H₂O₂
Own genomeNoYes (mtDNA)NoNo

Lipolysis vs lipophagy

PropertyCytosolic lipolysisLipophagy (autophagy)
LocationDroplet surface (cytosol)Autophagosome → lysosome
Key enzymesATGL → HSL → MGLLysosomal acid lipase (LIPA)
RegulatorsPKA, perilipins, CGI-58ATG genes, TFEB, Rab7
ProductFree fatty acids + glycerolFree fatty acids + glycerol
Dominant whenAcute hormonal demand (adrenaline, fasting onset)Prolonged fasting, esp. in liver
Handles damaged lipidsPoorlyWell (bulk degradation)
Disease linkATGL/HSL deficiency → neutral lipid storage diseaseLIPA deficiency → Wolman disease / CESD

History and landmark findings

  • Early sightings. Fat globules in cells were described by nineteenth-century microscopists, and the term "liposome" was even used for them before it came to mean artificial vesicles. For a century they were dismissed as passive fat inclusions rather than organelles.
  • Perilipin discovery (1991). Andrew Greenberg and Constantine Londos identified perilipin as the major PKA-phosphorylated protein coating adipocyte droplets, showing that a dedicated protein coat gates access to stored fat — the finding that reframed droplets as regulated organelles.
  • The droplet proteome (2000s). Proteomic surveys of purified droplets from yeast, fly, and mammalian cells revealed hundreds of specifically targeted proteins, cementing droplet status as a bona fide organelle with its own biology.
  • Seipin and lipodystrophy. Loss-of-function mutations in BSCL2 (seipin) cause Berardinelli-Seip congenital lipodystrophy: patients cannot build normal droplets, lack functional adipose tissue, and store fat ectopically in liver and muscle, developing severe insulin resistance — proving that healthy fat storage in droplets is protective, not merely cosmetic.
  • Lipophagy defined (2009). Rajat Singh, Ana Maria Cuervo, and colleagues showed in Nature that autophagy directly degrades lipid droplets in hepatocytes, and that blocking autophagy causes triacylglycerol to accumulate — establishing lipophagy as a genuine, distinct mobilization pathway.
  • PNPLA3 and human fatty liver (2008). A genome-wide association study by Jonathan Cohen and colleagues identified the PNPLA3 I148M variant, a droplet-surface lipase mutation, as the strongest common genetic risk factor for hepatic steatosis — direct human evidence that droplet-surface enzymology sets fatty-liver risk.

Frequently asked questions

Why is a lipid droplet bounded by a monolayer instead of a bilayer?

Every other organelle stores its contents in an aqueous lumen, so it needs a two-leaflet bilayer with a water-facing surface on both sides. A lipid droplet stores an oil — triacylglycerol and sterol esters that exclude water entirely. That oily core needs a surface facing outward to the cytosol but no inner water-facing leaflet, so a single phospholipid monolayer, roughly 2 to 3 nm thick, is the only topology that works. The monolayer is unusually rich in phosphatidylcholine and low in phosphatidylethanolamine, which keeps the surface stable and prevents droplets from fusing uncontrollably. This monolayer origin is a direct consequence of how droplets form: neutral lipids are synthesized between the two leaflets of the endoplasmic reticulum bilayer, accumulate as a lens, and bud toward the cytosol, carrying only the cytosolic leaflet with them. The monolayer is also why droplets host a specialized proteome — proteins target it either through amphipathic helices or hairpin membrane anchors, not the transmembrane domains that span a bilayer.

How do lipid droplets bud from the endoplasmic reticulum?

Droplet biogenesis begins when the ER-resident acyltransferases DGAT1, DGAT2 (which make triacylglycerol) and ACAT1/2 (which make sterol esters) esterify fatty acids and cholesterol into neutral lipids. These oily molecules are insoluble in the membrane and, once their local concentration exceeds roughly 5 to 10 mole percent, they demix and coalesce into a lens between the two leaflets of the ER bilayer. The protein seipin (encoded by BSCL2) oligomerizes into a cage-like ring that marks and stabilizes the nascent droplet, controlling its size and ensuring it stays connected to the ER for lipid delivery. As triacylglycerol accumulates, the lens bulges toward the cytosol and buds off, wrapped in the cytosolic monolayer. Membrane surface tension and the asymmetric distribution of phospholipids between the two leaflets bias budding toward the cytosolic face. Mutations in seipin cause Berardinelli-Seip congenital lipodystrophy, in which patients cannot make functional droplets and store fat ectopically in liver and muscle instead.

What do perilipins do on the surface of a lipid droplet?

Perilipins (PLIN1 through PLIN5) are the signature coat proteins of lipid droplets and act as gatekeepers of stored fat. PLIN1, the adipocyte-specific member, coats the droplet and shields it from lipases when the body is fed. When hormones like adrenaline signal an energy demand, protein kinase A phosphorylates both PLIN1 and hormone-sensitive lipase; phosphorylated PLIN1 releases the co-activator CGI-58 (ABHD5), which then activates adipose triglyceride lipase (ATGL) to begin stripping fatty acids. So perilipins are a molecular switch: they clamp the droplet shut in the fed state and unlock it on demand. Different family members tune different tissues — PLIN2 (adipophilin) and PLIN3 (TIP47) coat droplets in most cell types, PLIN5 is enriched in oxidative tissues like heart and muscle where it physically tethers droplets to mitochondria to channel fatty acids straight into oxidation. Mutations in PLIN1 cause a familial partial lipodystrophy with severe insulin resistance.

How do cells release the energy stored in lipid droplets?

Cells tap droplet energy through two parallel routes: lipolysis and lipophagy. Classical lipolysis is a stepwise enzymatic hydrolysis on the droplet surface. Adipose triglyceride lipase (ATGL), activated by its co-factor CGI-58, removes the first fatty acid to make diacylglycerol; hormone-sensitive lipase (HSL) removes the second to make monoacylglycerol; and monoacylglycerol lipase (MGL) removes the third, freeing glycerol. The three liberated fatty acids are exported and burned by beta-oxidation, yielding roughly nine kilocalories per gram — more than twice the energy density of carbohydrate. Lipophagy is the autophagic route: a portion of a droplet, or a whole small droplet, is engulfed by an autophagosome and delivered to the lysosome, where lysosomal acid lipase hydrolyzes the triacylglycerol. Lipophagy dominates in the liver during fasting and lets cells dispose of damaged or oxidized lipids. Both routes converge on free fatty acids that feed mitochondrial ATP production.

Are lipid droplets just inert fat blobs, or are they real organelles?

For most of the twentieth century textbooks treated lipid droplets as passive fat inclusions, not organelles. That view collapsed in the 1990s and 2000s. Droplets have a defined, regulated proteome of hundreds of proteins, a dedicated biogenesis machinery (seipin, DGAT, FIT2), and their own turnover pathways. They make physical membrane contact sites with the ER, mitochondria, peroxisomes, and the endosomal system, exchanging lipids and proteins across those junctions. Beyond energy, droplets sequester toxic free fatty acids and cholesterol to prevent lipotoxicity, store fat-soluble vitamins and signaling-lipid precursors, buffer proteins including histones in early embryos and unfolded ER proteins destined for degradation, and even hold antiviral and antibacterial roles. So they are bona fide, dynamic organelles that happen to store an oil — closer in spirit to a regulated fuel depot than an inert droplet.

How do lipid droplets cause fatty liver disease and obesity?

Obesity is fundamentally a disorder of lipid-droplet expansion. White adipocytes each hold one giant unilocular droplet that can swell until fat is 90 percent of the cell's volume; chronic caloric excess enlarges these droplets and recruits new adipocytes. When adipose storage is exhausted or dysfunctional, fat spills into organs never meant to store it. In the liver, triacylglycerol accumulates as cytoplasmic droplets, producing non-alcoholic fatty liver disease (now termed metabolic-dysfunction-associated steatotic liver disease, MASLD), the most common chronic liver disease worldwide, affecting roughly 25 to 30 percent of adults. When droplet-buffered lipids overflow into toxic intermediates — diacylglycerol and ceramide — they impair insulin signaling and drive inflammation, progressing to steatohepatitis, fibrosis, and cirrhosis. A polymorphism in PNPLA3 (I148M), a droplet-surface lipase, is the strongest common genetic risk factor for fatty liver. So the same organelle that safely warehouses fat becomes pathogenic when its capacity is overwhelmed.